Angio Suites Market by Type, Technology, Level of Automation, Application, End-User

List of Tables

[180 Pages Report] The Angio Suites Market size was estimated at USD 22.57 billion in 2023 and expected to reach USD 24.84 billion in 2024, at a CAGR 10.51% to reach USD 45.45 billion by 2030.

Angio suites, or angiography suites, are specialized facilities designed for performing vascular imaging procedures known as angiographies. These procedures help doctors visualize blood vessels in various parts of the body to diagnose and treat conditions such as blockages or abnormalities. The suite typically includes equipment for X-ray imaging and other diagnostic tools that help healthcare professionals view and treat the areas of interest with precision. In essence, angio suites are crucial in facilitating minimally invasive techniques for treating vascular diseases. As the prevalence of cardiovascular conditions such as coronary artery diseases and peripheral artery diseases continues to rise globally, there is an amplified demand for angio suites. These facilities are essential for performing minimally invasive surgeries that these conditions often require, thus driving the need for more advanced angio suites equipped with high-precision instruments. However, the high cost associated with the angio suites is a significant challenge faced by the companies. Moreover, the development of enhanced imaging technologies in angio suites, such as higher-resolution cameras and real-time imaging software, offers significant opportunities for market growth. These advancements improve the accuracy and efficiency of vascular and interventional procedures, thereby increasing the demand for modern angio suites equipped with the latest technology.

KEY MARKET STATISTICS
Base Year [2023]	USD 22.57 billion
Estimated Year [2024]	USD 24.84 billion
Forecast Year [2030]	USD 45.45 billion
CAGR (%)	10.51%

Regional Insights

The American market, particularly the United States and Canada, has been significant in the adoption of angio suites due to the high prevalence of cardiovascular diseases and significant healthcare spending. The region has an established healthcare infrastructure and a strong emphasis on research and innovation, accelerating the adoption of advanced medical technologies. Recent investments have focused on integrating AI and robotic technologies to enhance the precision and efficiency of angiographic procedures. At the same time, in the EMEA, there is a strong trend toward modernizing and expanding healthcare facilities, which includes updating existing angiography systems. Countries including Germany, France, and the United Kingdom are major in technology adoption due to their robust healthcare systems and active participation in clinical research. Recent EU regulations on medical devices (MDR) have also ensured higher safety and quality standards, influencing the market dynamics. Moreover, the Asia Pacific region demonstrates significant growth potential for angio suites. China's market is expanding rapidly due to large-scale healthcare reforms and increasing investment in healthcare infrastructure. Japan's older population shows sustained demand for cardiovascular procedures, thereby investing heavily in technologically advanced angio suites.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Angio Suites Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Increasing incidences of cardiovascular diseases worldwide and the need for effective diagnosis solutions
- Rising demand for next-generation imaging solutions for precise surgical interventions

Market Restraints
- High costs associated with the installation and maintenance of angio systems

Market Opportunities
- Continuous improvements in imaging technologies and procedural techniques
- Supportive government policies and investments for advanced healthcare infrastructure

Market Challenges
- Complexities associated with the integration of angio suites with existing systems

Market Segmentation Analysis
- Type: Integration of advanced suites in fixed angiography to enhance real-time imaging and immediate assessment
- Application: Increasing usage of angio suites in cardiology for angiographic examinations and interventions

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Angio Suites Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Angio Suites Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Philips Unveils Enhanced Azurion Neuro Biplane System for Improved Neurovascular Procedures

Philips has upgraded its Azurion image-guided therapy platform by introducing the advanced Azurion neuro biplane system. This new system enhances imaging capabilities and gantry positioning flexibility, optimizing the efficiency of neurovascular interventions. According to a recent press release from the company, the Azurion neuro biplane system aims to increase patient throughput and improve clinical outcomes. [Published On: 2024-02-27]

Enhancing Cardiovascular Health through Innovative Technology Collaboration

Mentice, a player in simulation solutions, and the University Center of Excellence (Unicen) announced a strategic collaboration to advance cardiovascular healthcare technologies. This collaboration integrates Mentice's expertise in high-fidelity simulations with Unicen's clinical research capabilities. The goal is to foster innovations that enhance teaching, improve procedural outcomes, and contribute to safer clinical practices. Such a collaboration promises to accelerate the development of cutting-edge technologies in the cardiovascular field and bridge the gap between clinical research and real-world medical applications, potentially leading to better patient outcomes on a global scale. [Published On: 2024-02-21]

Canon Medical Launches Alphenix / Evolve Edition Angiography System in Europe

Canon Medical released its Alphenix / Evolve Edition angiography system for the European market, featuring real-time Deep Learning technology. This advanced system optimizes image quality and strives to reduce both the duration and radiation exposure during Percutaneous Coronary Intervention (PCI) and Structural Heart Disease (SHD) procedures. Implementing this technology promotes enhanced safety for medical professionals and patients, aiming to lead to more efficient and safer healthcare outcomes in cardiovascular treatments. [Published On: 2023-08-07]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Angio Suites Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Angio Suites Market, highlighting leading vendors and their innovative profiles. These include 3D Systems, Inc., Canon Medical Systems Corporation, Carestream Health, Carl-Zeiss-Stiftung, Center for Vascular Diseases, Covenant Health, Esaote S.p.A, FUJIFILM Holdings Corporation, GE Healthcare, Guerbet, Hitachi, Ltd., Hologic, Inc., IMRIS, Inc., Koninklijke Philips N.V., Lam Vascular & Associates, Mentice AB, Mercy Health, MIOT International, Neurotexas, PLLC, ONEX Corporation, PLANMED OY, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shimadzu Corporation, Siemens Healthineers, Spain Commercial, Inc., Surrey and Sussex Healthcare NHS Trust, United Biologics Inc., Universal Health Services, Inc., UTMB Health, and Vascular Surgical Associates.

Market Segmentation & Coverage

This research report categorizes the Angio Suites Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Fixed Angio Suites
- Mobile Angio Suites

Technology
- Computed Tomography Angiography
- Digital Subtraction Angiography
- Magnetic Resonance Angiography

Level of Automation
- Fully Automated
- Manual
- Semi-Automated

Application
- Cardiology
- Neurology
- Oncology

End-User
- Diagnostic Centers
- Hospitals
- Specialty Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-99555D550524

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing incidences of cardiovascular diseases worldwide and the need for effective diagnosis solutions
  - 5.1.1.2. Rising demand for next-generation imaging solutions for precise surgical interventions
- 5.1.2. Restraints
  - 5.1.2.1. High costs associated with the installation and maintenance of angio systems
- 5.1.3. Opportunities
  - 5.1.3.1. Continuous improvements in imaging technologies and procedural techniques
  - 5.1.3.2. Supportive government policies and investments for advanced healthcare infrastructure
- 5.1.4. Challenges
  - 5.1.4.1. Complexities associated with the integration of angio suites with existing systems
5.2. Market Segmentation Analysis
- 5.2.1. Type: Integration of advanced suites in fixed angiography to enhance real-time imaging and immediate assessment
- 5.2.2. Application: Increasing usage of angio suites in cardiology for angiographic examinations and interventions
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Angio Suites Market, by Type

6.1. Introduction
6.2. Fixed Angio Suites
6.3. Mobile Angio Suites

7. Angio Suites Market, by Technology

7.1. Introduction
7.2. Computed Tomography Angiography
7.3. Digital Subtraction Angiography
7.4. Magnetic Resonance Angiography

8. Angio Suites Market, by Level of Automation

8.1. Introduction
8.2. Fully Automated
8.3. Manual
8.4. Semi-Automated

9. Angio Suites Market, by Application

9.1. Introduction
9.2. Cardiology
9.3. Neurology
9.4. Oncology

10. Angio Suites Market, by End-User

10.1. Introduction
10.2. Diagnostic Centers
10.3. Hospitals
10.4. Specialty Clinics

11. Americas Angio Suites Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Angio Suites Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Angio Suites Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
- 14.3.1. Philips Unveils Enhanced Azurion Neuro Biplane System for Improved Neurovascular Procedures
- 14.3.2. Enhancing Cardiovascular Health through Innovative Technology Collaboration
- 14.3.3. Canon Medical Launches Alphenix / Evolve Edition Angiography System in Europe
14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

15.1. Key Company Profiles
15.2. Key Product Portfolio